Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective epidural hydromorphone dose for latent-phase labor analgesia
ChiCTR1900021841Phase 4Not yet recruiting
- Sponsor
- Nanjing Maternal and Child Health Hospital
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hydromorphone in labor pain, sponsored by Nanjing Maternal and Child Health Hospital. Primary endpoint: VAS score. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR1900021841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021841.